Subaru Impreza Engine Failure Risk Results in Recall for 33k Vehicles

More than 33,000 Subaru Impreza vehicles have been recalled due to a risk that the engine may stall suddenly due to a reduction is fuel pressure, posing a serious accident risk.ย 

The Subaru Impreza recall was announced by the U.S. National Highway Traffic Safety Administration (NHTSA) on April 17, following several warranty claims where the vehicles stalled, resulting in loss of steering and inability to restart the engine. To date, no crash reports of injuries have been received.

Subaru of America first learned of the issue on January 3, after receiving a field report indicating the driver experienced a rough idle and engine stall event. After receiving several additional reports involving similar events, the manufacturer performed an engine analysis with the collected information and found the Engine Control Unit (ECU) software used to regulate the radiator fan needed to be corrected.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

According to the recall documents, when North American winter fuel is used in the engines, the fuel may begin to vaporize in the fuel line under higher ambient temperature, low speed, or stopped driving conditions, resulting in decreased fuel pressure. The premature evaporation of the fuel will result in a rough idling condition, engine stall or inability to restart the engine.

Subaru has determined that the software programming of the ECU, which operates the radiator fan, was not set to a low enough temperature by the manufacturer.

The recall includes 2017 Subaru Impreza four door vehicles that were manufactured from October 18, 2016 through March 17, 2017, and 2017 Subaru Impreza Station wagon vehicles manufactured from September 23, 2016 through March 21, 2017.

The vehicles were manufactured by Subaru of America, Inc. and were distributed for sale throughout the United States to licensed dealers.

The NHTSA warns that owners should be cautious when driving the recalled vehicles and be alert for any rough idling conditions that may be an indicator of lower fuel pressure events. The recall documents warn passengers that these unexpected stall events are most likely to occur during low speed driving, stop-and-go traffic, or when the vehicle is brought to a complete stop and idling.

Subaru will begin notifying owners of the issue and supply instructions on how to schedule a repair appointment at their local dealer, where dealers will be instructed to reprogram the engine control unit to turn the radiator cooling fan on at a lower temperature, free of charge. Subaru has not yet announced its notification or repair schedule, however owners with questions may contact Subaru Customer Service at 1-800-782-2783.

Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nationโ€™s leading personal injury law firms and oversees the siteโ€™s editorial strategy, including SEO and content development.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

An Illinois woman has joined a growing number of plaintiffs alleging that the Medtronic Intellis neurostimulator, and similar devices, may fail to relieve chronic pain and instead lead to worsening complications.
A federal judge is being asked to certify seven hair relaxer class action lawsuits seeking medical monitoring for users, following studies that link the products to an increased risk of cancer.